These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 1444557)
21. Effect of dexamethasone therapy on serum vitamin E concentrations in premature infants with bronchopulmonary dysplasia. Amin SB; Laroia N; Sinkin RA; Kendig JW J Perinatol; 2003 Oct; 23(7):552-5. PubMed ID: 14566351 [TBL] [Abstract][Full Text] [Related]
22. Pituitary-adrenal suppression and recovery in preterm very low birth weight infants after dexamethasone treatment for bronchopulmonary dysplasia. Ng PC; Wong GW; Lam CW; Lee CH; Fok TF; Wong MY; Wong W; Chan DC J Clin Endocrinol Metab; 1997 Aug; 82(8):2429-32. PubMed ID: 9253312 [TBL] [Abstract][Full Text] [Related]
23. Vitamin A and bronchopulmonary dysplasia: research, issues, and clinical practice. Mentro AM Neonatal Netw; 2004; 23(4):19-23. PubMed ID: 15317375 [TBL] [Abstract][Full Text] [Related]
24. The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Kelly EJ; Chatfield SL; Brownlee KG; Ng PC; Newell SJ; Dear PR; Primrose JN Arch Dis Child; 1993 Jul; 69(1 Spec No):37-9. PubMed ID: 8346951 [TBL] [Abstract][Full Text] [Related]
30. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Onland W; Offringa M; De Jaegere AP; van Kaam AH Pediatrics; 2009 Jan; 123(1):367-77. PubMed ID: 19117904 [TBL] [Abstract][Full Text] [Related]
31. Catabolic effect in premature infants with early dexamethasone treatment. Tsai FJ; Tsai CH; Wu SF; Liu YH; Yeh TF Acta Paediatr; 1996 Dec; 85(12):1487-90. PubMed ID: 9001663 [TBL] [Abstract][Full Text] [Related]
32. High-mobility group box-1 protein in tracheal aspirates from premature infants: relationship with bronchopulmonary dysplasia and steroid therapy. Aghai ZH; Saslow JG; Meniru C; Porter C; Eydelman R; Bhat V; Stahl G; Sannoh S; Pyon K; Hewitt C; Bhandari V J Perinatol; 2010 Sep; 30(9):610-5. PubMed ID: 20182437 [TBL] [Abstract][Full Text] [Related]
33. Partial parenteral nutrition in preterm and newborn infants during the first three days of life. Henze G; Lautner H; Neubrand W; Werner E JPEN J Parenter Enteral Nutr; 1979; 3(4):231-4. PubMed ID: 113590 [TBL] [Abstract][Full Text] [Related]
34. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Brand PL; van Lingen RA; Brus F; Talsma MD; Elzenga NJ Acta Paediatr; 1993; 82(6-7):614-7. PubMed ID: 8339005 [TBL] [Abstract][Full Text] [Related]
35. Lysosomal enzymes in preterm infants with bronchopulmonary dysplasia: a potential diagnostic marker. Goi G; Bairati C; Massaccesi L; Lombardo A; Bonafè L; Zanardo V; Burlina A Clin Chim Acta; 1998 Nov; 278(1):23-34. PubMed ID: 9877121 [TBL] [Abstract][Full Text] [Related]